Preoperative HO-1 Levels as Prognostic Factor for Adverse Cardiac Events in Elder Patients Undergoing Non-Cardiac Surgery

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Zheng, Hong ^a   Ma, Hai Ping ^a   Wang, Jiang ^a   Ma, Ming ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TROPONIN I;

ACUTE HEART INFARCTION; ADVERSE OUTCOME; AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; ECG ABNORMALITY; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PATIENT IDENTIFICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROGNOSIS; RISK ASSESSMENT; SEX DIFFERENCE;

AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; BIOLOGICAL MARKERS; FEMALE; HEART DISEASES; HEART FAILURE; HEME OXYGENASE-1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PROGNOSIS; RISK FACTORS; TROPONIN I;

EID: 84875098473     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058567     Document Type: Article

References (24)

1. Romero L, de Virgilio C, (2001) Preoperative cardiac risk assessment: an undated approach. Arch Surg 136: 1370-1376.
2. Auerbach AD, Goldman L, (2002) beta-Blockers and reduction of cardiac events in noncardiac surgery: clinical applications. JAMA 287: 1445-1447.
3. Eckle T, Köhler D, Lehmann R, El Kasmi K, Eltzschig HK, (2008) Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation 118: 166-175.
4. Semenza GL, (2000) HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88: 1475-1480.
5. Jewell UR, Kvietikova I, Scheid A, Bauer C, Wenger RH, et al. (2001) Induction of HIF-1a in response to hypoxia is instantaneous. FASEB J 15: 1312-1314.
6. Huang LE, Gu J, Schau M, Bunn HF, (1998) Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A 95: 7987-7992.
7. Durante W, (2003) Heme oxygenase-1 in growth control and its clinical application to vascular disease. J Cell Physiol 195: 373-382.
8. Abbate A, Biondi-Zoccai GG, Baldi A, (2002) Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling. J Cell Physiol 193: 145-153.
9. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, et al. (2007) ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary:A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evalution for Noncardiac Surgery): Developed in Collaboration With the American Society of Echocardiograpry, American Society of Nuclear Cardiaology, Heart Rhythm Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 116: e418-e500.
10. Chinese Society of Cardiology, the Chinese Medical Association, the Editorial Board of the Chinese Journal of Cardiology (2001) Acute myocardial diagnosis and treatment guidelines. Chin J Cardiol 29: 710-725 (in Chinese).
11. Criteria Committee New York Heart Association Inc (1964) Diseases of the heart and blood vessels. Nomenclature and criteria for diagnoses. 6th edition. Little Brown: Boston. 114 p.
12. American Society of Anesthesiologists (1963) New classification of physical status. Anesthesiology 24: 111.
13. Wolters U, Wolf T, Stützer H, Schröder T, (1996) ASA classification and perioperative variables as perioperative variables as predictors of postoperative outcome. Br J Anaesth 77: 217-222.
14. Novo G, Corrado E, Tortorici E, Novo A, Agrusa A, et al. (2011) Cardiac risk stratification in elective non-cardiac surgery: role of NT-proBNP. Int Angiol 30: 242-246.
15. Kim SE, Park DG, Lee JH, Han KR, Oh DJ, (2011) Utility of B-type natriuretic Peptide for predicting perioperative cardiovascular events in patients without history of cardiovascular disease undergoing major non-cardiac surgery. Korean Circ J 41: 11-15.
16. Mercantini P, Di Somma S, Magrini L, Kazemi Nava A, Scarinci A, et al. (2012) Preoperative brain natriuretic peptide (BNP) is a better predictor of adverse cardiac events compared to preoperative scoring system in patients who underwent abdominal surgery. World J Surg 36: 24-30.
17. Goei D, Poldermans D, (2010) Screening value of N-terminal pro-B-type natriuretic peptide as a predictor of perioperative cardiac events after noncardiac surgery. Future Cardiol 6: 603-609.
18. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, et al. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107: 43-54.
19. Abbate A, Bussani R, Biondi-Zoccai GG, Santini D, Petrolini A, et al. (2005) Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium. Eur Heart J 26: 2039-2045.
20. Hölscher M, Schäfer K, Krull S, Farhat K, Hesse A, et al. (2012) Unfavourable consequences of chronic cardiac HIF-1α stabilization. Cardiovas Res 94: 77-86.
21. Patten DA, Lafleur VN, Robitaille GA, Chan DA, Giaccia AJ, et al. (2010) Hypoxia-inducible factor-1 activation in nonhypoxic conditions: the essential role of mitochondrial-derived reactive oxygen species. Mol Biol Cell 21: 3247-3257.
22. Larsen K, Cheng C, Duckers HJ, (2010) Regulation of vulnerable plaque development by the heme oxygenase/carbon monoxide system. Trends Cardiovasc Med 20: 58-65.
23. Li YG, Wang DM, Chen SM, Tan XR, Fang XY, et al. (2006) Heme oxygenase-1 expression and coronary heart disease-association between levels of haem oxygenase-1 expression and angiographic morphology as well as quantity of coronary lesions. Acta Cardiol 61: 295-300.
24. Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, et al. (2001) Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 89: 168-173.